The screening test to evaluate QT prolongation(Toxicity Screening Strategy in Early Stage Drug Development : Current Situation and Perspective, Proceedings of the 32nd Annual Meeting)

スポンサーリンク

概要

• 論文の詳細を見る
• 日本トキシコロジー学会の論文
• 2005-10-31

著者

• Kasai Chieko

  Drug Safety Research Laboratories Astellas Pharma Inc.

• Hombo Toshiyasu

  Drug Safety Research Laboratories Astellas Pharma Inc.

• Hombo Toshiyasu

  Drug Safety Research Labs. Astellas Pharma Inc.

• TOKORO Kazumi

  Drug Safety Research Labs. Astellas Pharma Inc.

関連論文

• Questionnaire survey on cardiac electrophysiology examination in safety pharmacology studies.(GENERAL SESSION BY POSTER PRESENTATION)(SAFETY PHARMACOLOGY)
• QT PRODACT : Comparison of Non-clinical Studies for Drug-Induced Delay in Ventricular Repolarization and Their Role in Safety Evaluation in Humans
• QT PRODACT : In Vivo QT Assay With a Conscious Monkey for Assessment of the Potential for Drug-Induced QT Interval Prolongation
• QT PRODACT : Evaluation of the Potential of Compounds to Cause QT Interval Prolongation by Action Potential Assays Using Guinea-Pig Papillary Muscles
• QT PRODACT : A Multi-site Study of In Vitro Action Potential Assays on 21 Compounds in Isolated Guinea-Pig Papillary Muscles
• The screening test to evaluate QT prolongation(Toxicity Screening Strategy in Early Stage Drug Development : Current Situation and Perspective, Proceedings of the 32nd Annual Meeting)

スポンサーリンク